Hims & Hers Health (HIMS) Cash from Operations (2019 - 2026)
Hims & Hers Health (HIMS) posted Cash from Operations of 89356000.0 for Q1 2026, up 45.74% sequentially from 61312000.0 in Q4 2025, and down 18.09% YoY from 109090000.0 in Q1 2025.
Hims & Hers Health (HIMS) Cash from Operations (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Cash from Operations for 8 years, with the latest figure at 89356000.0 in Q1 2026.
- Quarterly Cash from Operations fell 18.09% year-over-year to 89356000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 280272000.0 (down 16.17% YoY) and the FY2025 annual result came in at 300006000.0, up 19.48% from the prior year.
- Cash from Operations grew to 89356000.0 in Q1 2026 per HIMS's latest filing, from 61312000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 148721000.0 in Q3 2025 and troughed at 19403000.0 in Q1 2022.
- A 5-year average of 40435176.47 and a median of 25191000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations sank 1163.89% in 2022, then surged 427.18% in 2023.
- Over 5 years, Cash from Operations stood at 6719000.0 in 2022, then soared by 427.18% to 21983000.0 in 2023, then soared by 292.96% to 86385000.0 in 2024, then declined by 29.02% to 61312000.0 in 2025, then surged by 45.74% to 89356000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 89356000.0, 61312000.0, and 148721000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | -35.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.94 Mn |
| Jun 30, 2026 | -35.94 Mn |
| Mar 31, 2026 | 89.36 Mn |
| Mar 31, 2026 | 89.36 Mn |
| Dec 31, 2025 | 61.31 Mn |
| Dec 31, 2025 | 61.31 Mn |
| Sep 30, 2025 | 148.72 Mn |
| Sep 30, 2025 | 148.72 Mn |
| Jun 30, 2025 | -19.12 Mn |
| Jun 30, 2025 | -19.12 Mn |
| Mar 31, 2025 | 109.09 Mn |
| Mar 31, 2025 | 109.09 Mn |
| Dec 31, 2024 | 86.39 Mn |
| Dec 31, 2024 | 86.39 Mn |
| Sep 30, 2024 | 85.27 Mn |
| Sep 30, 2024 | 85.27 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Mar 31, 2024 | 25.84 Mn |
| Mar 31, 2024 | 25.84 Mn |